SLRX
Salarius Pharmaceuticals Inc. Common Stock
$0.707+-0.000 (-0.000%)
Reaalajas hind
Hinnagraafik
Loading Chart...
Põhinäitajad
Turunäitajad
Avatud
$0.707
Kõrge
$0.707
Madal
$0.707
Maht
0.07M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
GlobeNewswire
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
CAMBRIDGE, Mass. and HOUSTON, March 26, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide-conjugate
Vaata rohkem
GlobeNewswire
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and
Vaata rohkem
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.